-
摘要: 随着人类免疫缺陷病毒(human immunodeficiency virus，HIV)感染人群数目的逐渐增多，同时HIV感染患者的寿命也逐渐延长，这类人群也越来越重视生活质量以及对疾病的治疗情况。而对于泌尿外科来说，肾结石是一种常见的疾病，不仅表现在普通人群，也表现在HIV感染人群中，因此对HIV感染人群肾结石的流行病学及其治疗深入探讨是很有必要的。Abstract: As the number of people infected with HIV increases gradually, and the life expectancy of people infected with HIV increases gradually, such people also pay more and more attention to the quality of life and treatment of the disease. For urology, kidney stones are a common disease, not only in the general population, but also in HIV-infected people. Therefore, it is necessary to explore the epidemiology and treatment of kidney stones in HIV-infected people.
-
Key words:
- human immunodeficiency virus /
- kidney stone /
- epidemiology /
- treatment
-
-
[1] Antiretroviral Therapy Cohort Collaboration. Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies[J]. Lancet HIV, 2017, 4(8): e349-e356. doi: 10.1016/S2352-3018(17)30066-8
[2] Shiels MS, Islam JY, Rosenberg PS, et al. Projected Cancer Incidence Rates and Burden of Incident Cancer Cases in HIV-Infected Adults in the United States Through 2030[J]. Ann Intern Med, 2018, 168(12): 866-873. doi: 10.7326/M17-2499
[3] Rukin NJ, Siddiqui ZA, Chedgy E, et al. Trends in Upper Tract Stone Disease in England: Evidence from the Hospital Episodes Statistics Database[J]. Urol Int, 2017, 98(4): 391-396. doi: 10.1159/000449510
[4] Sorokin I, Mamoulakis C, Miyazawa K, et al. Epidemiology of stone disease across the world[J]. World J Urol, 2017, 35(9): 1301-1320. doi: 10.1007/s00345-017-2008-6
[5] Giovanni G, Giovanni D, Antonio B. Urolithiasis associated with atazanavir may mask a metabolic 'channelling' bias[J]. J Antimicrob Chemother, 2014, 69(1): 284-285. doi: 10.1093/jac/dkt306
[6] Lin KY, Liao SH, Liu WC, et al. Cholelithiasis and Nephrolithiasis in HIV-Positive Patients in the Era of Combination Antiretroviral Therapy[J]. PLoS One, 2015, 10(9): e0137660. doi: 10.1371/journal.pone.0137660
[7] Nishijima T, Hamada Y, Watanabe K, et al. Ritonavir-boosted darunavir is rarely associated with nephrolithiasis compared with ritonavir-boosted atazanavir in HIV-infected patients[J]. PLoS One, 2013, 8(10): e77268. doi: 10.1371/journal.pone.0077268
[8] Yang CJ, Wang HY, Chou TC, et al. Prevalence and related drug cost of comorbidities in HIV-infected patients receiving highly active antiretroviral therapy in Taiwan: A cross-sectional study[J]. J Microbiol Immunol Infect, 2019, 52(5): 720-727. doi: 10.1016/j.jmii.2019.05.011
[9] de Lastours V, Ferrari Rafael De Silva E, Daudon M, et al. High levels of atazanavir and darunavir in urine and crystalluria in asymptomatic patients[J]. J Antimicrob Chemother, 2013, 68(8): 1850-1856. doi: 10.1093/jac/dkt125
[10] 谷现恩. 茚地那韦尿路结石[J]. 中国新药与临床杂志, 2004, 23(7): 444-446. doi: 10.3969/j.issn.1007-7669.2004.07.019
[11] 李金华. 人类免疫缺陷病毒(HIV)阳性患者的Indinavir尿结石病: 治疗和预防[J]. 中华泌尿外科杂志, 2004, 25(8): 28. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHMN200408013.htm
[12] Lanzafame M, Bonora S, Lattuada E, et al. Disappearance of renal stones in an HIV-1-infected patient after reduction of atazanavir dose[J]. AIDS Res Hum Retroviruses, 2014, 30(9): 835-836. doi: 10.1089/aid.2014.0134
[13] Raheem OA, Mirheydar HS, Palazzi K, et al. Prevalence of nephrolithiasis in human immunodeficiency virus infected patients on the highly active antiretroviral therapy[J]. J Endourol, 2012, 26(8): 1095-1098. doi: 10.1089/end.2011.0639
[14] Hamada Y, Nishijima T, Watanabe K, et al. High incidence of renal stones among HIV-infected patients on ritonavir-boosted atazanavir than in those receiving other protease inhibitor-containing antiretroviral therapy[J]. Clin Infect Dis, 2012, 55(9): 1262-1269. doi: 10.1093/cid/cis621
[15] Izzedine H, Lescure FX, Bonnet F. HIV medication-based urolithiasis[J]. Clin Kidney J, 2014, 7(2): 121-126. doi: 10.1093/ckj/sfu008
[16] Rockwood N, Mandalia S, Bower M, et al. Ritonavir-boosted atazanavir exposure is associated with an increased rate of renal stones compared with efavirenz, ritonavir-boosted lopinavir and ritonavir-boosted darunavir[J]. AIDS, 2011, 25(13): 1671-1673. doi: 10.1097/QAD.0b013e32834a1cd6
[17] Raheem OA, Mirheydar HS, Palazzi K, et al. Prevalence of nephrolithiasis in human immunodeficiency virus infected patients on the highly active antiretroviral therapy[J]. J Endourol, 2012, 26(8): 1095-1098. doi: 10.1089/end.2011.0639
[18] Scales CD Jr, Smith AC, Hanley JM, et al. Prevalence of kidney stones in the United States[J]. Eur Urol, 2012, 62(1): 160-165. doi: 10.1016/j.eururo.2012.03.052
[19] Strope SA, Wolf JS Jr, Hollenbeck BK. Changes in gender distribution of urinary stone disease[J]. Urology, 2010, 75(3): 543-546, 546.e1. doi: 10.1016/j.urology.2009.08.007
[20] Knoll T, Schubert AB, Fahlenkamp D, et al. Urolithiasis through the ages: data on more than 200, 000 urinary stone analyses[J]. J Urol, 2011, 185(4): 1304-1311. doi: 10.1016/j.juro.2010.11.073
[21] Ziemba JB, Matlaga BR. Epidemiology and economics of nephrolithiasis[J]. Investig Clin Urol, 2017, 58(5): 299-306. doi: 10.4111/icu.2017.58.5.299
[22] Reid E, Suneja G, Ambinder RF, et al. Cancer in People Living With HIV, Version 1.2018[J]. NCCN, 2018, 16(8): 986-1017.
[23] 中国性病艾滋病防治协会学术委员会外科学组, 中华医学会热带病与寄生虫学分会外科学组. 中国人类免疫缺陷病毒感染者围手术期抗病毒治疗专家共识[J/OL]. 中华实验和临床感染病杂志(电子版), 2019, 13(1): 1-5.
[24] Guild GN, Moore TJ, Barnes W, et al. CD4 count is associated with postoperative infection in patients with orthopaedic trauma who are HIV positive[J]. Clin Orthop Relat Res, 2012, 470(5): 1507-1512. doi: 10.1007/s11999-011-2223-1
[25] 程传宇, 郝建伟, 武玉东, 等. HIV感染肾结石患者行输尿管软镜钬激光碎石术后发生尿路感染的危险因素分析[J]. 中华泌尿外科杂志, 2019, 40(9): 690-694. doi: 10.3760/cma.j.issn.1000-6702.2019.09.010
[26] Horberg MA, Hurley LB, Klein DB, et al. Surgical outcomes in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy[J]. Arch Surg, 2006, 141(12): 1238-1245. doi: 10.1001/archsurg.141.12.1238
[27] Regez RM, Kleipool AE, Speekenbrink RG, et al. The risk of needle stick accidents during surgical procedures: HIV-1 viral load in blood and bone marrow[J]. Int J STD AIDS, 2005, 16(10): 671-672. doi: 10.1258/095646205774357280
[28] Edmiston CE Jr, Zhou SS, Hoerner P, et al. Evaluation of an antimicrobial surgical glove to inactivate live human immunodeficiency virus following simulated glove puncture[J]. Surgery, 2013, 153(2): 225-233. doi: 10.1016/j.surg.2012.07.034
[29] Melo MG, Sprinz E, Gorbach PM, et al. HIV-1 heterosexual transmission and association with sexually transmitted infections in the era of treatment as prevention[J]. Int J Infect Dis, 2019, 87: 128-134. doi: 10.1016/j.ijid.2019.08.004
[30] Babadoko AA, Aminu SM, Suleiman AN. Neutropenia and human immunodeficiency virus-1 infection: analysis of 43 cases[J]. Niger J Med, 2008, 17(1): 57-60.
[31] Isgrò A, Aiuti A, Mezzaroma I, et al. Improvement of interleukin 2 production, clonogenic capability and restoration of stromal cell function in human immunodeficiency virus-type-1 patients after highly active antiretroviral therapy[J]. Br J Haematol, 2002, 118(3): 864-874. doi: 10.1046/j.1365-2141.2002.03680.x
[32] Yaseen MM, Abuharfeil NM, Yaseen MM, et al. The role of polymorphonuclear neutrophils during HIV-1 infection[J]. Arch Virol, 2018, 163(1): 1-21. doi: 10.1007/s00705-017-3569-9
[33] Sabih A, Leslie SW. Complicated Urinary Tract Infections[M]. Treasure Island: StatPearls Publishing, 2022.
[34] 沈柏华, 林奕伟. 输尿管软镜碎石术相关尿源性脓毒症的防治策略[J]. 临床泌尿外科杂志, 2020, 35(9): 696-698. https://www.cnki.com.cn/Article/CJFDTOTAL-LCMW202009006.htm
[35] Davis NF, Quinlan MR, Poyet C, et al. Miniaturised percutaneous nephrolithotomy versus flexible ureteropyeloscopy: a systematic review and meta-analysis comparing clinical efficacy and safety profile[J]. World J Urol, 2018, 36(7): 1127-1138. doi: 10.1007/s00345-018-2230-x
[36] Li MM, Yang HM, Liu XM, et al. Retrograde intrarenal surgery vs miniaturized percutaneous nephrolithotomy to treat lower pole renal stones 1.5-2.5 cm in diameter[J]. World J Clin Cases, 2018, 6(15): 931-935. doi: 10.12998/wjcc.v6.i15.931
[37] Mzingwane ML, Hunt G, Lassauniere R, et al. Detection and molecular characterization of urinary tract HIV-1 populations[J]. Ann Clin Microbiol Antimicrob, 2019, 18(1): 27. doi: 10.1186/s12941-019-0326-9
[38] 周雄才, 范立新, 董超雄, 等. HIV/AIDS合并泌尿外科疾病腔镜手术的安全性探讨[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2018, 12(6): 390-393.
[39] 纪世琪, 赵洪亮, 韩志兴, 等. 输尿管软镜下钬激光碎石取石术治疗43例HIV阳性患者的疗效及安全性分析[J]. 现代泌尿外科杂志, 2019, 24(4): 272-274, 279. https://www.cnki.com.cn/Article/CJFDTOTAL-MNWK201904009.htm
[40] 杨玉春. 输尿管软镜下钬激光碎石术与开放手术治疗输尿管上段结石并HIV感染者的疗效分析[J]. 临床研究, 2018, 26(4): 112-114. https://www.cnki.com.cn/Article/CJFDTOTAL-LCYN201804058.htm
[41] Torricelli FC, Monga M, Dall'Aqua V, et al. Percutaneous nephrolithotomy in immunocompromised patients: outcomes from a matched case-control study[J]. J Endourol, 2016, 30(12): 1326-1331. doi: 10.1089/end.2016.0496
[42] 刘玉荣. 血清降钙素原与C-反应蛋白水平检测对患者早期感染的诊断[J]. 健康大视野, 2018, (22): 46. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHYY201502013.htm
[43] Wu H, Zhu S, Yu S, et al. Early drastic decrease in white blood count can predict uroseptic shock induced by upper urinary tract endoscopic lithotripsy: a translational study[J]. J Urol, 2015, 193(6): 2116-2122. doi: 10.1016/j.juro.2015.01.071
[44] Fan J, Wan S, Liu L, et al. Predictors for uroseptic shock in patients who undergo minimally invasive percutaneous nephrolithotomy[J]. Urolithiasis, 2017, 45(6): 573-578. doi: 10.1007/s00240-017-0963-4
-
计量
- 文章访问数: 1270
- PDF下载数: 475
- 施引文献: 0
下载: